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Pseudomonas aeruginosa is one of the main causative agents of nosocomial infections
and the spread of multidrug-resistant strains is rising. Therefore, novel strategies for
therapy are urgently required. The outer membrane composition of Gram-negative
pathogens and especially of Pa restricts the efficacy of antibiotic entry into the cell
and determines virulence. For efficient outer membrane protein biogenesis, the β-barrel
assembly machinery (BAM) complex in the outer membrane and periplasmic chaperones
like Skp and SurA are crucial. Previous studies indicated that the importance of individual
proteins involved in outer membrane protein biogenesis may vary between different
Gram-negative species. In addition, since multidrug-resistant Pa strains pose a serious
global threat, the interference with both virulence and antibiotic resistance by disturbing
outer membrane protein biogenesis might be a new strategy to cope with this challenge.
Therefore, deletion mutants of the non-essential BAM complex components bamB and
bamC, of the skp homolog hlpA as well as a conditional mutant of surAwere investigated.
The most profound effects for both traits were associated with reduced levels of SurA,
characterized by increased membrane permeability, enhanced sensitivity to antibiotic
treatment and attenuation of virulence in a Galleria mellonella infection model. Strikingly,
the depletion of SurA in a multidrug-resistant clinical bloodstream isolate re-sensitized
the strain to antibiotic treatment. From our data we conclude that SurA of Pa serves as a
promising target for developing a drug that shows antiinfective activity and re-sensitizes
multidrug-resistant strains to antibiotics.
Keywords: SurA, Pseudomonas aeruginosa, virulence, multidrug resistance, antibiotics, outer membrane protein
biogenesis
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INTRODUCTION
The widespread use of antibiotics is causative for the rapid
development of multidrug-resistant strains. Particularly, the
emergence of carbapenem-resistant bacteria poses a significant
threat to public health (Pendleton et al., 2013). The Gram-
negative, opportunistic pathogen Pseudomonas aeruginosa (Pa)
belongs to the so-called ESKAPE group, comprising a group
of the most common and multidrug-resistant bacteria (Rice,
2008). Pa can cause infections in a wide range of animal and
plant hosts and is a leading cause of nosocomial infections,
which are almost exclusively found in immunocompromised
hosts (Lyczak et al., 2000; Lister et al., 2009). Pa displays
numerous intrinsic and acquired resistance mechanism against
antibiotics: (i) enzymatic and mutational resistance mechanisms
like the production of β-lactamases, (ii) overexpression of
eﬄux systems, and (iii) the low permeability of the outer
membrane (OM) that limits the penetration of antibiotic
molecules (Yoshimura and Nikaido, 1982).
The major challenge for drugs against Pa and Gram-negative
bacteria in general is to pass the bacterial OM. The OM
provides a highly effective barrier against foreign and harmful
molecules, allows import and export of essential substances
such as nutrients and iron, is necessary for communication
and harbors many virulence factors. The outer leaflet of the
OM is constituted mainly by lipopolysaccharides (LPS), whereas
the inner leaflet consists of phospholipids. This bilayer houses
a great variety of outer membrane proteins (OMPs) that
facilitate transport and other essential functions, and act as
virulence factors (Nikaido, 2003). Many OMPs are porins and
autotransporters. Both comprise a β-barrel domain and either
facilitate transport of molecules across the OM (Chevalier
et al., 2017) or can form cell surface exposed moieties that
shape the interaction with the host and the extracellular
environment (Leyton et al., 2012). For the insertion of these
β-barrel proteins, Gram-negative bacteria employ a conserved
transport system consisting of the periplasmic chaperones SurA,
Skp, and DegP, which protect and guide newly synthesized
proteins from the Sec translocon in the inner membrane to
the OM and the β-barrel assembly machinery (BAM) complex
(Sklar et al., 2007; Tashiro et al., 2009; Goemans et al.,
2014; Li et al., 2018). Both SurA and Skp act as chaperones
and are thought to form a partially redundant network. The
importance of SurA and Skp for the OMP biogenesis is
controversially discussed. At least in Escherichia coli (Ec) and
Yersinia enterocolitica (Ye), SurA plays the major and Skp a less
prominent role in folding and assembly of OMPs (Sklar et al.,
2007; Volokhina et al., 2011; Weirich et al., 2017). However,
in Neisseria mengitidis, Skp is more important for shaping
the OMP composition than SurA, indicating species-specific
differences (Tamae et al., 2008).
The BAM complex, which inserts the β-barrel proteins
into the OM, consists of the central component BamA
and the four lipoproteins BamB, BamC, BamD, and BamE
(Noinaj et al., 2017). Of these subunits, only BamA and
BamD are essential in most of the so far investigated Gram-
negative bacteria, except Borrelia burgdorferi and Salmonella
enterica (Wu et al., 2005; Malinverni et al., 2006; Fardini
et al., 2009; Dunn et al., 2015). BamA is a β-barrel protein
itself (Noinaj et al., 2017). Its C-terminal β-barrel domain is
connected to an N-terminal periplasmic domain which consists
of five polypeptide transport-associated (POTRA) domains.
The POTRA domains form several interactions with the other
Bam subunits, building up the BAM complex and interact
with both substrates and periplasmic chaperones such as
SurA (Gu et al., 2016). BamB directly binds to the POTRA
domains 2-5 of BamA and supports the stabilization of
nascent OMPs by binding and delivering OMP β-strands to
BamA (Heuck et al., 2011).
In Ec, the deletion of one of the non-essential BAM complex
components or the related periplasmic shuttle protein SurA
may lead to an altered protein composition in the OM and/or
disturbed OM integrity and therefore to a higher susceptibility
to various antibiotics (Behrens et al., 2001; Onufryk et al.,
2005). Using Ye we have previously shown that the deletion
of surA and bamB implies a significantly decreased virulence
and more efficient clearance of Ye infection by the host in vivo
(Weirich et al., 2017).
In Pa, BamA, and the BamE-homolog OmlA have already
been recognized to play a role in the stability of the OM
and susceptibility to environmental stress (Ochsner et al., 1999;
Yorgey et al., 2001; Hoang et al., 2011). For BamB of Pa, an
enhanced susceptibility against lysozyme and cell wall targeting
antibiotics as well as a decreased growth in vivo have been
demonstrated recently (Lee et al., 2017).
Thus, it is well recognized that the BAM complex itself as well
as chaperones in delivering proteins to the outer membrane are
critical for membrane integrity as well as antibiotic resistance
and could therefore be targets for drug development (Tamae
et al., 2008; Weirich et al., 2017; Storek et al., 2018; Vij et al.,
2018). Nevertheless, previous studies revealed species-specific
differences in the importance of individual components in OMP
biogenesis such as Skp and SurA (Sklar et al., 2007; Volokhina
et al., 2011; Weirich et al., 2017). In addition, for considering
such proteins as targets for Pa it would be mandatory to
affect multidrug-resistant strains and break resistance against
commonly used antibiotics.
To identify potential targets in order to possibly develop
new strategies to treat especially infections caused by multidrug-
resistant Pa, we investigated the role of components involved
in the assembly of proteins into the OM by deletion of the
non-essential BAM complex components BamB and a BamC
homolog as well as the periplasmic shuttle proteins SurA and
HlpA (a Skp-like protein) in Pa PA14. Depletion of SurA had
the greatest impact on OM integrity and caused profound
changes in the protein composition of the OM. These changes
broadened the spectrum of antibiotics that could be used for
treatment of Pa infection, and they lowered the minimum
inhibitory concentration of clinically important antibiotics.
Additionally, depletion of SurA enhanced clearance of Pa
infection by the host. Taken together, our findings indicate
that specifically SurA could serve as a novel antivirulence
and/or resistance-breaking target even in multidrug-resistant
strains of Pa.
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MATERIALS AND METHODS
Bacterial Strains and Culture Conditions
Bacterial strains and plasmids used in this study are listed in
Table S1. Bacteria were cultivated overnight at 37◦Cwith shaking
at 200 rpm in lysogeny broth (LB) containing suitable antibiotics
but without any additives such as arabinose, if not otherwise
stated. Antibiotics were added at the following concentrations:
Tetracycline (Tet; AppliChem #A2228) 15µg/ml, ampicillin
(Amp; AppliChem #A0839) 100µg/ml and gentamicin (Gm;
AppliChem #A1492) 15µg/ml (Ec strains) or 75µg/ml for Gm
and 50µg/ml for Tet (Pa strains). If not stated otherwise,
overnight cultures were diluted 1:20 into fresh LB medium
containing suitable antibiotics (and/or additives like 0.2%
arabinose (Sigma Aldrich #A3256) for the conditional surA
mutant) and grown for 3 h at 37◦C and 200 rpm to obtain
subcultures in exponential phase (OD600 = 0.5). The growth of
bacteria in LB at 37◦C in a 24-well-plate was measured using
Tecan Infinite R© 200 PRO at 37◦C. To investigate the growth
under iron-restricted conditions, indicated concentrations of
2,2′-Bipyridyl (Sigma Aldrich #D216305) were added.
Generation of In-frame Deletion Mutants
In-frame deletion mutants were generated using the suicide
plasmid pEXG2 (Rietsch et al., 2005). The primers used in this
study are listed in Table S2. First, the flanking regions (consisting
of 30 bp at the 3′ end and 30 bp at the 5′ end of the gene of
interest plus ∼ 800 bp for each flanking region) and a pEXG2
fragment were amplified by PCR and ligated using Gibson
assembly (Gibson, 2009). In general, constructed plasmids were
verified by DNA sequencing, transformed into Ec SM10 λ pir and
subsequently mobilized by conjugation into PA14. Merodiploids
were selected on LB agar plates containing irgasan (25µg/ml;
Sigma Aldrich #72779) and Gm (75µg/ml). To achieve the
second cross-over, counter selection on no-salt lysogeny broth
(NSLB) agar containing 15% sucrose was performed (Sigma
Aldrich #S7903). Finally, the loss of the plasmid was tested by
streaking colonies on LB agar plates containing Gm (75µg/ml)
and in parallel on LB agar plates without antibiotics. In-frame
deletion mutants were confirmed by PCR using (i) a primer pair
flanking the target gene and (ii) a primer pair where one primer
binds to the coding region of the target gene.
Generation of Conditional Depletion
Mutants
As stated also in the results section, we were not able to create an
in-frame surA deletion mutant. Therefore, a conditional mutant
was generated, starting from a merodiploid PA14::pEXG2-surA
clone. For the integration of exogenous surA, the plasmid mini-
CTX1-araCPBAD-surA (PA14) was constructed. The mini-CTX1
(Hoang et al., 2000) is an optimized self-proficient integration
vector for Pa containing a ϕCTX attachment site for integration
of foreign genes into the chromosome. The coding sequence
(cds) of tolB of the vector mini-CTX1-araCPBAD-tolB (Lo Sciuto
et al., 2014) was replaced by the cds of surA using PCR
amplification and Gibson assembly. The mini-CTX1-araCPBAD-
surA construct was integrated into the attB neutral site of the
chromosome of PA14::pEXG2-surA as described recently (Hoang
et al., 2000; Lo Sciuto et al., 2014) in the presence of Tet
(50µg/ml), Gm (100µg/ml) and arabinose (0.2%). Afterwards,
the endogenous copy of the surA gene was deleted in-frame
under SurA-inducing conditions and confirmed as described
above. Excision of the mini-CTX1 backbone containing the
Tet resistance cassette was performed using Flp recombinase as
described (Hoang et al., 2000) and verified by PCR. Likewise,
a conditional surA mutant of the clinical Pa isolate ID72 was
generated, using mini-CTX1-araCPBAD-surA and the mutator
plasmid pEXG2-surA ID72. For the complementation of bamB,
the mini-CTX1 vector was used to introduce an arabinose-
inducible copy of bamB into the genome of PA14 bamB as
described for surA.
Electron Microscopy
A total of 5 x 109 bacteria were harvested and fixed in Karnovsky’s
fixative, embedded in agarose, cut in small blocks and fixed again
in Karnovsky’s fixative. After post-fixation and embedding in
glycid ether, blocks were cut using an ultramicrotome. Sections
(30 nm) were mounted on copper grids and analyzed using a
Zeiss LIBRA transmission electron microscope.
Generation of Overexpression Plasmids for
Protein Purification
The cds of PA14 surA was subcloned into the vector
pTXB1, resulting in pTXB1-surA-Intein. pET28a-bamB-His6
was generated by Genscript Inc. Both plasmids were transformed
into Ec BL21 (DE3) (Invitrogen #C600003). The sequence
encoding full-length plpD from Pa PAO1 was synthesized with
Ec codon optimization (ThermoFisher Scientific). The region
coding for the passenger and the POTRA domain (residues
18-406) were subcloned into the expression vector pET28a+
(Novagen #69864) using Gibson assembly with mutations
leading to an inactive lipase and encoding a C-terminal
hexa-histidine tag resulting in pET28a-plpD S60A/D207N-
His (Liu and Naismith, 2008).
Protein Purification and Generation of
Polyclonal Antibodies
For purification of SurA, Ec BL21 (DE3) harboring pTXB1-
surA-Intein was grown to an OD600 of 0.4, induced by the
addition of 100µM IPTG (Peqlab #37-2020) and grown for
another 4 h at 37◦C. Protein purification was performed using
the IMPACTTM kit (New England Biolab #E6901S) according to
the manufacturer’s instructions with subsequent size-exclusion
chromatography on a HiLoadTM 16/600 SuperdexTM 200 pg
column (GE Lifesciences). Fractions containing purified SurA
were pooled, concentrated and validated by SDS-PAGE. For
purification of BamB, Ec BL21 (DE3) harboring pTXB1-bamB-
His6 were grown to an OD600 of 0.6, induced by the addition
of 100µM IPTG and grown overnight at 37◦C. Bacteria
were pelleted and resuspended in buffer A [40mM HEPES
(Carl Roth #9105.4), pH 7.4; 150mM NaCl (VWR Chemicals
#27810.295)] following an incubation under stirring for 20min
at 4◦C with 10mM MgSO4 (AppliChem #A6414), 20 mg/ml
lysozyme (Sigma Aldrich #6876), protease inhibitor tablets
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(Sigma Aldrich #S8830) and a pinch of DNase (Sigma Aldrich
#DN25). Subsequently, bacteria were lysed using a French
pressure cell, followed by sequential centrifugation steps at
4◦C (4,500 × g, 15min; 20,000 × g, 20min; 40,000 × g,
1 h). Finally, the sterile-filtered (0.2µm filter, Sarstedt) His6-
tagged protein was subjected to metal affinity chromatography
(HisTrapTM HP, 5ml, GE Life Sciences) and concentrated.
Antibodies were raised in 2 rabbits each for SurA or BamB-His6
and subsequently affinity-purified against purified SurA or BamB
protein, respectively (Eurogentec).
For purification of PlpD lipase + POTRA domains, Ec BL21
Gold (DE3) cells (Agilent Technologies #230132) harboring
pET28a-plpD S60A/D207N-His were grown in autoinducing
ZYP-5052 medium (Studier, 2005) at 30◦C, harvested 24 h
post-inoculation by centrifugation and resuspended in running
buffer containing 40mM sodium phosphate (Carl Roth #K300.1),
400mM NaCl and 20mM imidazole, pH 8.0 (AppliChem
#A1073). For lysis, additional EDTA-free protease inhibitor,
1mM MgCl2 (Sigma Aldrich #M8266), 1mM MnCl2 (Merck
#8059300100), 0.1 mg/ml lysozyme and a pinch of DNase were
added to the buffer before application to a French pressure cell.
After centrifugation at 20,000 × g and 4◦C for 35min, the
sterile-filtered supernatant containing the His6-tagged protein
was applied to a HisTrapTm FF column (GE Healthcare) and
purified on an NGC Chromatography System (Bio-Rad). The
protein was eluted from the column using a gradient of imidazole
(to 0.5M) and further purified on a HiPrep 26/60 Sephacryl S200
HR size exclusion column (GE Healthcare, USA) using 20mM
Tris and 300mM NaCl at pH 7.5. The production of antibodies
was performed at the Section for Experimental Biomedicine
(University of Life Sciences, Oslo, Norway) with license of the
Norwegian Animal Research Authority (NARA) (http://www.
mattilsynet.no/dyr_og_dyrehold/dyrevelferd/forsoksdyr/).
NPN Assay
To determine changes in the OM permeability of the
generated mutants, the fluorescent, hydrophobic 1-N-
phenylnaphthylamine (NPN) (Acros organics #90-30-2)
was used as described (Konovalova et al., 2016). Subcultured
bacteria were washed and adjusted to an OD600 of 0.5 in
5mM HEPES buffer (pH 7.2). NPN was added to the bacteria
to a final concentration of 10µM. 200 µl of the bacterial
suspension were transferred to 96-well F-bottom, black, non-
binding plates (Greiner Bio-one #89089-582). Subsequently,
fluorescence (excitation and emission wavelengths 350 and
420 nm, respectively) was measured using the Tecan Infinite R©
200 PRO. Polymyxin B (PMB, Merck #A 231-40) served as
a positive control and was added to a final concentration
of 8µg/ml. Values obtained for a buffer-only control were
subtracted from all values.
Bile Salt Assay
To analyze the sensitivity to bile salts, 107 bacteria per well
were inoculated in duplicates into a 24 well microtiter plate
containing either 1ml LB or 1ml LB + 0.3 % bile salts (Sigma
Aldrich #B8756). The conditional surA mutant was additionally
supplemented with 0.2 % arabinose. The plate was incubated at
37◦C and shaking at 160 rpm for 8 h and OD600 was determined
using the Tecan Infinite R© 200 PRO.
Western Blot Analysis
5 × 108 bacteria per ml of subcultures grown for 3 h were boiled
in 2.5× Laemmli buffer (Bio-Rad #161-0747) containing 50mM
DTT (Thermo Fisher Scientific #R0861) at 95◦C for 10min.
SDS-PAGE was performed with 5 × 106 bacteria per lane using
a 10 % Mini-PROTEAN R© TGXTM Precast Protein gel (Bio-
Rad). Subsequently, proteins were transferred to a nitrocellulose
membrane. After blocking in 5% skim milk in TBS (10mM Tris-
HCL (Sigma #T1503), 150mM NaCl; pH 7.6), the membrane
was incubated with the primary antibody [rabbit anti-SurA,
1:200; rabbit anti-BamB-His6, 1:200; rabbit anti-OprD (kindly
provided by Thilo Köhler, University of Geneva; Epp et al.,
2001), 1:2,000; rabbit anti-PlpD serum 1:10,000; rabbit anti-RpoB
(Ec), 1:2,000 (Abcam #mAb EPR18704)] and afterwards with
the secondary antibody (horseradish-peroxidase-conjugated goat
anti-rabbit antibody 1:5,000, Thermo Fisher Scientific #31460).
ClarityTM Western ECL Substrate (Bio-Rad #170-5061) was
added and signals were detected using a Fusion Solo S imager
(Vilber). Protein bands were quantified via ImageJ. In contrast to
SurA and OprD, where RpoB was used as a loading control for
quantification, for PlpD the unspecific band of ∼75 kDa served
as a loading control.
Enrichment of OM Fractions
Preparation of the OM was conducted as described (Thein
et al., 2010; Oberhettinger et al., 2015; Weirich et al., 2017).
In short, PA14 strains including the conditional surA mutant
were grown overnight in LB. Subcultures (1:20 dilution) were
then grown in LB to an OD600 of 0.5–0.7. For complementation
of the conditional surA mutant 0.2% arabinose was added
in the subculture. After centrifugation, 2.5 × 1010 bacteria
were resuspended in 0.5ml of resuspension buffer (0.2M Tris,
1M sucrose, 1mM EDTA (Applichem #A5097), pH 8.0), then
5,000U lysozyme were added and incubated for 5min at
room temperature. Subsequently, 3.2ml H2O were added and
incubated for 20min at room temperature until spheroplasts
were formed. Then, 5ml of extraction buffer (2% Triton X-
100 (AppliChem #A4975), 50mM Tris, 10mM MgCl2, pH
8.0) together with 5 µl DNase I (Roche Applied Science
#03539121103) were added and incubated on a rotator for 20min
at room temperature to solubilize the inner membrane fraction
with Triton X-100 (Schnaitman, 1971; Page and Taylor, 1988).
The lysate was centrifuged at 85,000 × g for 1 h at 4◦C and
the pellet containing the OM fraction was washed three times
in 2.5ml H2O by centrifugation at 292,000 × g for 15min at
4◦C. The pellet containing the OM fraction was resuspended
in 300 µl H2O.
NanoLC-MS/MS Analysis and Data
Processing
The protein concentration of the OM samples was measured
using the PierceTM BCA Protein Assay Kit (Thermo Fisher
Scientific #23225). 10 µg of each sample was subjected to SDS-
PAGE and stained with Roti R©-Blue Colloidal Coomassie Staining
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Solution. OM fractions were analyzed as described previously
(Weirich et al., 2017) with slight modification: Coomassie-
stained gel pieces were digested in-gel with trypsin (Borchert
et al., 2010), and desalted peptide mixtures (Rappsilber et al.,
2007) were separated on an Easy-nLC 1200 (Thermo Scientific)
system coupled to an LTQ Orbitrap Elite mass spectrometer
(Thermo Scientific). The peptide mixtures were injected onto the
column in HPLC solvent A (0.1% formic acid) at a flow rate of
500 nl/min and subsequently eluted with an 127min segmented
gradient of 5-33-50-90% of HPLC solvent B (80% acetonitrile
in 0.1% formic acid) at a flow rate of 200 nl/min. The mass
spectrometer was operated in positive ionmode, and spectra were
recorded in a mass range from m/z 300 to 2000 with a resolution
of 120,000. The 15 most intense ions were sequentially isolated
and fragmented in the linear ion trap using collision-induced
dissociation (CID) and default CID settings. The target values
for MS scans and MS/ MS fragmentation were 106 and 5,000
charges, respectively. Sequenced precursor masses were excluded
from further selection for 60 s.
Acquired MS spectra were processed with MaxQuant
software package version 1.5.2.8 (Cox and Mann, 2008) with
integrated Andromeda search engine (Elias and Gygi, 2007).
Database search was performed against a target-decoy Pa
UCBPP-PA14 database obtained from Uniprot, containing 5886
protein entries, and 285 commonly observed contaminants.
Endoprotease trypsin was defined as protease with a maximum
of two missed cleavages. Oxidation of methionine and N-
terminal acetylation were specified as variable modifications, and
carbamidomethylation on cysteine was set as fixed modification.
Initial maximum allowed mass tolerance was set to 4.5 ppm (for
the survey scan) and 0.5 Da for CID fragment ions. Peptide,
protein and modification site identifications were reported at a
false discovery rate (FDR) of 0.01, estimated by the target/decoy
approach (Elias and Gygi, 2007). The label-free algorithm was
enabled, as was the “match between runs” option (Luber et al.,
2010). The detection limit was calculated as the mean of the
lowest label-free quantification (LFQ) values of each sample.
Multiple t-tests were performed and FDR of differences in the
log2 protein amount between mutant and wild type (WT) were
assessed using the two-stage step-up method (Benjamini et al.,
2006) with GraphPad Prism 7.04 software. Differences in protein
amount with a FDR< 0.1 were considered significant.
The mass spectrometry proteomics data have been
deposited to the ProteomeXchange Consortium via the
PRIDE (Vizcaino et al., 2016) partner repository with the dataset
identifier PXD011849 (Username: reviewer54276@ebi.ac.uk,
Password: i3rXLDrr).
RNA Isolation and qRT-PCR
5 × 109 bacteria grown as described for the mass spectrometry
analyses were resuspended in 1ml TRIzolTM Reagent (Thermo
Fisher Scientific #15596018). RNA isolation and DNase digestion
were conducted as described previously (Goerke et al., 2000;
Münzenmayer et al., 2016). The RNA (0.1 µg/µl in RNA storage
solution, Invitrogen #AM7000) was diluted 1:10 with RNase-free
water (Ambion #AM9937). To exclude samples with detectable
DNA contamination, a quantitative PCR using the QuantiFast
SYBR Green PCR Kit (Qiagen # 204054) for the house keeping
gene gyrB was performed. mRNA expression was assessed by
quantitative RT-PCR using the QuantiFast SYBR Green qRT-
PCR Kit (Qiagen # 204154) according to the manufacturer. A
standard curve was generated by a serial dilution of one sample.
Efficiency of the PCR and Cp values were calculated with the help
of LightCycler480 software (Roche). Relative quantification was
conducted as described by Pfaﬄ (Pfaﬄ, 2001). The used primers
are listed in Table S2.
Serum Killing Assay
A serum killing assay was performed using the BacTiter-GloTM
Microbial Cell Viability Assay (Promega) as described (Necchi
et al., 2017) with slight modifications. Normal human serum
(NHS) from healthy donors (Transfusion medicine, University
hospital Tübingen) was stored in aliquots at −80◦C. Heat
inactivated serum (HIS) was generated by incubating the serum
at 56◦C for 30min immediately before use. 5 × 106 bacteria
were incubated at 37◦C in 100 µl 10% HIS- or 10% NHS-PBS in
a 96 well V-bottom microtiter plate (Greiner bio-one #651101)
in triplicates for various time periods. After that, plates were
centrifuged at 3,500 × g for 5min and the pelleted bacteria
were resuspended in 100 µl PBS (GibcoTM #14040-091). To
determine the number of viable bacterial cells, 50 µl bacterial
suspension and 50 µl BacTiter-GloTM reagent (Promega #G8321)
were transferred to a white lumitrac 96 well F-bottom microtiter
plate (Greiner bio-one #655075) and the ATP levels inside the
bacteria were quantified with a Tecan Infinite R© 200 PRO.
Galleria mellonella Infection Model
Galleria mellonella (TruLarvTM) larvae were purchased from
Biosystems Technology. Subcultured bacteria were serially
diluted to 103/ml in PBS. Each G. mellonella larva was injected
with 10 µl of 103/ml bacterial dilution using a 30 gauge syringe
(BD Biosciences). The larvae were then incubated at 37◦C and
monitored for 3 days after infection. Larvae were considered dead
when no movement could be triggered by touching the larvae
with a forceps. Ten microliter aliquots of the bacterial dilutions
injected into the larvae were plated in triplicates on LB agar plates
and the CFU was determined. The mean administered bacterial
dose for all experiments was 12± 2 bacteria.
Antibiotic Susceptibility Testing
For determination of antibiotic susceptibility, bacterial strains
were grown at 37◦C overnight. Physiological sodium chloride
solution was inoculated to a McFarland standard of 0.5. From
this solution, bacteria were streaked with cotton swabs onto
Mueller-Hinton agar plates with or without 0.2 % arabinose.
E-tests (Liofilchem) were conducted according to CLSI standard
protocols to test the sensitivity of the different strains for
the following antibiotics: ampicillin/sulbactam (#92070);
piperacillin/ tazobactam (#92108); ticarcillin/ clavulanic acid
(#921171); doripenem (#92040); meropenem (#920840);
cefotaxime (#920061); cefepime (#921271); ceftazidime
(#921380); levofloxacin (#92081); ciprofloxacin (#920450);
fosfomycin (#920790); vancomycin (#920570); erythromycin
(#92051); trimethoprim/ sulfamethoxazole (#921231).
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Statistics
Statistics were performed using GraphPad Prism 7.04 software as
described for each experiment in the table or figure legends.
RESULTS
Generation of Pa Strains Carrying
Deletions for BAM Complex Components
and Periplasmic Chaperones
The BAM complex and associated chaperones may be interesting
targets for developing novel drugs against Gram-negative
bacteria. Their inhibition could possibly re-sensitize Gram-
negative pathogens to antibiotics to which they are resistant or
enable the use of antibiotics typically not being able to cross the
OM barrier and thus not applicable for treatment of infection
with Gram-negative pathogens (e.g., vancomycin) (Sydenham
et al., 2000; Rolhion et al., 2005; Fardini et al., 2009;Weirich et al.,
2017). Because of the clinical importance and increasing numbers
of multidrug-resistant strains we addressed the role of Pa BamB
(PA14_14910), BamC (PA14_51260), the Skp-like protein HlpA
(PA14_17170), and SurA (PA14_07760) for fitness and virulence
of Pa in order to determine which factorsmight be the best targets
for drug development. For this purpose we generated single gene
deletions, which were verified by PCR using genomic DNA as
template. Mass spectrometry analyses of OM fractions (typically
highly contaminated with cytoplasmic proteins) of the bamB,
bamC, and hlpA deletion strains compared to wild type (WT)
revealed the absence of the corresponding proteins (highlighted
in boldface in Table S3B).
Although we initiated numerous attempts, we were not able to
generate a surA deletion mutant. As an alternative, we created a
stable and unmarked PA14 surA conditional mutant harboring
an arabinose-inducible copy of the surA coding sequence,
resulting in the conditional surAmutant1surA araC-PBAD-surA
(Figure 1A), for convenience termed surA. Complementation
of surA was achieved by the addition of 0.2 % arabinose to
the culture media where appropriate (termed surA SurA+). To
check for expression of surA, mRNA levels were determined
by quantitative RT-PCR, using gyrB as a housekeeping gene
(Table S4). The relative number of mRNA transcripts of the
conditional surA mutant grown in the absence of arabinose
was reduced by 92 % compared to bacteria harvested after
growth in the presence of arabinose (surA SurA+). Therefore,
in the absence of arabinose surA is still expressed in a low
amount because the araC-PBAD promoter is leaky and cannot
be repressed by catabolite repression (Meisner and Goldberg,
2016). In addition, we assessed the presence of SurA protein in
whole cell lysates by Western blot analysis (Figure 1B). Using
the conditional surAmutant, SurA protein could not be detected
after growth in the absence of arabinose indicating a SurA protein
level below the detection limit of the Western blot analysis, while
production of SurA was restored in the presence of arabinose.
Growth of the (conditional) mutants was investigated at 37◦C in
LB medium (Figure 1C). Only a slight but significant reduction
in growth (p< 0.01) was observed between 6 h and 12 h after start
of the experiment for the conditional surAmutant, while all other
mutants grew comparably to the PA14 WT strain.
SurA and BamB Are Important for OM
Integrity
Integrity of the OM is a pivotal feature of Gram-negative
bacteria mediating protection against drugs and harsh
environments including mucosal surfaces with antimicrobial
peptide production. Since SurA delivers OMPs to the OM, where
they are inserted by the BAM complex, an inhibition of parts of
this pathway should result in an altered OM composition and
possibly a reduced OM integrity. To evaluate changes in OM
integrity induced by SurA depletion, or bamB, bamC or hlpA
deletion, we first performed a 1-N-phenylnaphthylamine (NPN)
assay. NPN fluoresces only in hydrophobic environments. Thus,
if the integrity of the OM is compromised in one of the mutant
strains, NPN can reach the phospholipid bilayer of the inner
OM leaflet more efficiently (Konovalova et al., 2016). Higher
fluorescence values therefore indicate a reduced OM integrity. It
was shown previously that disturbance of the OM by polymyxin
B (PMB) leads to a strong and significant increase of NPN
fluorescence. Therefore, PMB was used as a positive control in
our assay (Figure 2A). We found that the depletion of SurA,
but not the deletion of bamB, bamC or hlpA led to a significant
increase of fluorescence, compared to the wildtype strain
(WT). This means that only the depletion of SurA significantly
enhances the entry of NPN. The complementation of surA by
growing the strain in the presence of arabinose (surA SurA+)
resulted in a NPN fluorescence signal comparable to that of
PA14 WT, indicating that the phenotype can be fully restored by
the complementation.
Next we investigated the susceptibility to bile salts, which act
as physiological detergents in the intestinal tract (Merritt and
Donaldson, 2009). Treatment with 0.3% bile salts significantly
reduced the growth of the (conditional) surA, bamB, and bamC
mutants, but not of the hlpAmutant or surA SurA+ (Figure 2B).
For complementation of the bamB deletionmutant, amini-CTX1
plasmid expressing bamB under the control of an arabinose-
inducible promoter was introduced and induced with 0.2%
arabinose (bamB BamB+).
Depletion of SurA and BamB Induces
Morphological Changes of Pa
Since we had observed that both SurA and to a lesser extent
BamB have an impact on OM integrity of Pa, we were interested
if these changes result in obvious morphological changes.
For this purpose, PA14 WT, the bamB and the conditional
surA mutant strains grown in the presence or absence of
arabinose were harvested, fixed in Karnovsky’s fixative and
visualized by transmission electron microscopy (Figure S1).
The morphology of the PA14 WT strain was characterized by
regular-shaped cells with a continuous, plain surface without
any vesicles or protrusions attached. The BamB-deficient strain
very much resembled the phenotype of a corresponding Ye
mutant strain (Weirich et al., 2017). It was characterized by
numerous vesicles attached to the cell surface, probably a sign
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FIGURE 1 | Scheme of the conditional surA mutant, verification and impact of SurA, BamB, BamC and HlpA on Pa growth. (A) Schematic view of the genomic
organization of the conditional surA mutant. (B) Western blot analysis of SurA and RpoB of PA14 WT and the conditional surA mutant in the absence (surA) and
presence of 0.2% arabinose (surA SurA+). (C) Growth curves of indicated strains. Data depict the mean and SD of at least 3 experiments. Growth curve of the
conditional surA mutant is highlighted in red. ANOVA analyses revealed significant differences (p < 0.01) for both WT vs surA and surA SurA+ vs surA in the time
range between 6 and 12 h.
FIGURE 2 | Role of SurA, BamB, BamC, and HlpA for membrane integrity and sensitivity against bile salts. (A) NPN Assay. A conditional surA and bamB, bamC, and
hlpA deletion mutants were treated with NPN. Data depict the mean and SD of 3–5 independent experiments with triplicates. The fluorescence signal derived from
matched numbers of bacteria was compared to that of WT. Polymyxin B (PMB) was used as a positive control. Asterisks indicate significant differences (p < 0.05)
compared to WT using ANOVA analysis. (B) Bile Salt Assay. Growth of the indicated Pa strains was measured in the absence or presence of 0.3 % bile salts after 8 h.
Data depict the mean and SD of the growth reduction in 0.3 % bile salts in LB compared to LB alone of at least 3 independent experiments with duplicates. Asterisks
indicate significant differences (****p < 0.0001 or *p < 0.05) as analyzed by ANOVA analysis.
for envelope stress (Kulp and Kuehn, 2010). Cells of the SurA
depletion strain grown in the absence of arabinose also appeared
rather regular-shaped, however, they looked slightly bloated and
had some vesicles attached to their surface. Taken together,
both a bamB and a conditional surA mutant of Pa showed
visible changes in cell morphology, which corroborates previous
findings obtained with Ye.
Depletion of SurA Results in a Drastically
Altered Composition of OMPs
To analyze the OMP composition, OM fractions of WT and
mutants were prepared and semi-quantitative proteomic analysis
was performed using tryptic in-gel digestion and LC-MS/MS
analysis. The ratio of label-free quantification (LFQ) intensities
between the mutants and the WT was calculated. All differences
in log2 LFQ intensities with a false discovery rate (FDR) <0.1
were considered significant. A list of all significant alterations is
found in Table S3 (S3A: OMPs, S3B: all proteins). For the raw
data please refer to http://proteomecentral.proteomexchange.
org/cgi/GetDataset with the dataset identifier PXD011849.
The deletion mutant strains for hlpA, bamC and bamB
exhibited just minor changes. In the hlpA deletion mutant, only
HlpA was reduced in abundance, as it was no longer detectable in
the OM fraction. The bamC deletion led to a significant reduction
only of OmpH. Deletion of bamB led to a reduction of quite
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a number of proteins (e.g. FecA, OprB, PlpD) also found to
be reduced in the SurA-depleted strain, however these changes
were not significant according to our selection criteria. The
relatively mild alterations in the OM composition may explain
the comparably weak phenotypes of the hlpA, bamC and bamB
deletion mutants with regards to OM integrity.
More interesting were the effects observed for SurA: depletion
of SurA significantly altered the level of 42 proteins predicted to
be localized in the OM (Table 1). Essentially, three groups could
be differentiated: (i) proteins highly abundant in the OM of the
WT but not detectable in the OM fraction of the conditional
surAmutant (ratio surA/WT< 0.01). This group included TonB-
dependent receptors and the siderophore receptors FpvA, FiuA
and FecA, and Type V secretion systems (autotransporters).
(ii) Proteins highly abundant in the OM fraction of WT and
significantly reduced more than 3-fold in the OM fraction of
surA. This group included proteins of the BAM complex and
porins (e.g., OprD, OprF, OprH). Finally (iii) a small group of
proteins that showed higher protein levels in the OM fraction
of the conditional surA mutant (e.g., OprM, OpmG, OpmB)
compared to the WT.
In order to find out if the changes in protein abundance
were caused on the transcriptional level, we assessed the relative
mRNA levels of selected genes from the different functional
groups of OMPs of the SurA depletion strain (grown exactly
as for the mass spectrometry analyses) by quantitative RT-PCR
and compared to the WT (Figure S2). From the genes tested,
elevated amounts of mRNA transcripts were only found for hlpA
(2.4-fold), which might be a regulatory effect to compensate
the reduced level of SurA. The transcriptional level of all other
investigated genes was comparable for all WT, the conditional
surA mutant and surA SurA+. These results indicate that the
genes including the type Vd autotransporter PlpD (Salacha et al.,
2010) and porins such as OprD seem to be true substrates of
SurA and that their reduced abundance in the OM is probably
the result of degradation within the periplasm.
Validation of MS/MS Findings: Verification
of Selected OMP Levels by Western Blot
Analyses
To further validate the proteomics data, the protein levels
of SurA, OprD, and PlpD of the WT and the mutants were
determined in whole cell lysates by Western blot analysis
(Figures 3A,B). Comparable RpoB levels in all samples
demonstrate equal loading of the lanes. Under depleting
conditions (surA), no SurA was detectable by Western
blot analysis demonstrating that the depletion worked well.
Production of SurA in the surA SurA+ sample shows at least
a partial recovery (64%) compared to the PA14 WT strain. In
accordance with the proteomics data (Table 1 and Figure 3C),
we found a decreased amount of OprD (15%) and PlpD (24%)
in the whole cell lysate of the conditional surA mutant. As
the PlpD antibody resulted in several bands in Western blot,
a plpD deletion strain was employed to identify the band
corresponding to PlpD.
Validation of MS/MS Findings: Impact of
Reduced Siderophore Receptor
Abundance
As a consequence of the highly reduced levels of siderophore
receptors (FpvA, FiuA, and FecA) under SurA-depleted
conditions we assumed that the strain might suffer from a
defective uptake of siderophore-iron complexes. Under iron-
restricted conditions this should consequently lead to a growth
reduction. Therefore, we assessed the growth characteristics
of PA14 and the surA mutant under iron limitation. This was
achieved by the addition of various amounts of the iron chelator
2,2′-Bipyridyl (BiP) to the growth medium (Figure S3). As
assumed, under iron limitation (+BiP), the SurA-depleted strain
exhibited a significantly stronger BiP dose-dependent growth
defect compared to the WT.
Depletion of SurA Increases the
Susceptibility for Killing by the
Complement System
An important first line host defense against invading bacteria
specifically in bloodstream infection is the serum complement
system. Therefore, we investigated whether serum resistance of
Pa is altered in the (conditional) surA, bamB, bamC, and hlpA
mutants. To this end, serum killing tests using human serumwere
performed. The strains were incubated in 10% heat inactivated
serum (HIS) or 10 % normal human serum (NHS). Survival
of bacteria was then quantified at indicated time points over a
maximum period of 4 h (Figure 4A). While deletion of bamB,
bamC or hlpA had no impact on survival in active serum, the
conditional surA mutant was killed rapidly when grown in the
absence of arabinose (Figure 4B), indicating that the depletion of
SurA alters the OM in a way that renders Pa highly susceptible to
killing by the serum complement system.
SurA Is Important for Virulence of Pa in the
Galleria mellonella Infection Model
To address the importance of the investigated genes for virulence,
the Galleria mellonella infection model was used. For this
purpose, 12 ± 2 cells of PA14 WT or the (conditional) surA,
bamB, bamC or hlpA mutant were injected into the hemolymph
of G. mellonella larvae. Thereafter, the survival of the larvae was
monitored (Figure 5). Neither deletion of bamB, bamC, nor hlpA
altered the survival compared to infection with theWT.However,
infection with the conditional surA mutant led to a significant
delay in the time to death. The conditional surA mutant was
grown under two growth conditions prior to infection: (i)
arabinose induced–SurA present prior to infection (SurA+) or
(ii) uninduced–SurA absent prior to infection (SurA–). However,
no significant difference was found between the survival curves
of SurA+ and SurA–. This indicates that SurA production
may decline rather quickly under in vivo conditions without
continuous application of arabinose, which was not applicable in
our experimental setting. Therefore, we could not test whether
a complementation would fully rescue virulence. Nevertheless,
our data demonstrate that SurA is critical for virulence of Pa
in G. mellonella.
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TABLE 1 | Outer membrane proteins affected by SurA depletion.
Function Gene name Ratio surA/WT β-strands PDB ID**
Type V secretion PA14_32780 <0.01 16*
PA14_32790 <0.01 –
PA14_61190 0.23 16*
PlpD <0.01 16 5F4A, 5FQU
AaaA (PA14_04290) <0.01 12*
EprS (PA14_18630) 0.04 12*
EstA 0.20 12 3KVN
Siderophore receptors and other
TonB-dependent receptors
FpvA <0.01 22 2W75, 2W16
FecA <0.01 22 1PO0, 1PO3
FiuA 0.04 22*
PA14_34990 <0.01 22*
PA14_54180 <0.01 22*
PA14_26420 0.02 22*
BAM-complex BamD/ComL 0.30 –
BamA 0.31 16 4C4V
BamE/OmlA 0.31 –
BamB 0.35 –
BamC (PA14_51260) 0.84 –
Porins OpdO <0.01 18 2Y0K, 2Y06
OpdN <0.01 18 4FSO
OprG 0.07 8 2X27
OprE 0.11 18*
Porins OpdP 0.13 18 3SYB
OprD 0.14 18 3SY7
OprB 0.22 16 4GY, 4GF
OprQ 0.25 22*
OprC 0.28 22*
OprH 0.32 8 2LHF
OpdC (PA14_02020) 0.35 18 3SY9
OprF 0.47 8 4RLC
PA14_31680 0.55 –
OprM 1.52 4 3D5K
OpmB (PA14_31920) 1.88 4*
OpmG 7.37 4*
LPS bio-synthesis LptD 0.32 26 5IVA
LptE 0.38 –
T3SS ExsB (PA14 42400) <0.01 –
Others Gbt <0.01 4*
FadL (PA14_60730) <0.01 14 3DWO
PA14_13130 0.03 –
PA14_24360 0.04 –
PA14_36020 7.28 –
FusA (PA14_13520) >20.40 4*
OM fractions of PA14 WT and the conditional surA mutant derived from three independent experiments were analyzed by mass spectrometry. Table depicts proteins which are described
to be located in the OM and are significantly reduced or increased due to SurA depletion. Multiple t-testing was performed. Significant differences (FDR < 0.1) are shown in bold face.
Number of β-strands of β-barrel proteins is indicated. *Predicted with Boctopus (Hayat and Elofsson, 2012); **Accession number of protein data bank (www.rcsb.org) of indicated
proteins or orthologs.
Susceptibility to Antibiotics
The impermeability of the OM is the main reason that
many antibiotics are not effective against Gram-negative
bacteria, since they cannot pass the OM to reach their
target. To investigate whether the depletion of SurA or
BamB influences antibiotic susceptibility, we performed a
comprehensive analysis with E-tests using the bamB deletion
mutant, the conditional surA strains of PA14 and the clinical
multidrug-resistant Pa bloodstream isolate ID72 (Willmann
et al., 2018) [resistant against 3 classes out of the following:
(I) 3rd and 4th generation cephalosporines (e.g., cefotaxim,
ceftazidim), (II) acylureidopenicillins (e.g., piperacillin), (III)
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FIGURE 3 | Validation of proteome analysis by Western blot. (A) Comparison of protein levels between WT and mutants. Bacteria as indicated were sub-cultured for
3 h in the presence or absence of arabinose and samples were harvested for preparation of whole cell lysates. Western blot analysis was performed for RpoB, SurA,
OprD, and PlpD. (B) Quantification of immunoblots from 3 to 5 independent experiments using ImageJ software. Pixel intensity corresponds to protein levels.
Asterisks indicate significant differences (*p < 0.05, **p < 0.01, ***p < 0.001) between compared groups using ANOVA analysis. (C) Quantification of mass
spectrometry analysis for OprD and PlpD. Graph indicates the LFQ intensity of OM fractions of indicated proteins. Asterisks indicate significant differences compared
to WT by performing multiple t-tests with a FDR < 0.1 (n = 3).
FIGURE 4 | SurA deletion leads to increased serum sensitivity. Indicated bacterial strains were grown for (A) various time periods or (B) 2 h and subsequently,
luciferase activity (which is directly proportional to the ATP levels of viable cells in a sample) was measured. Data depict the mean and SD of luciferase activity
measured of 3 independent experiments performed in triplicates. Asterisks indicate significant differences (p < 0.0001) analyzed by one way ANOVA analysis.
fluorchinolones (e.g., ciprofloxacin), and (IV) carbapenems (e.g.,
imipenem, meropenem)] (Figure S4) and the corresponding
complemented strains compared to the WT control strains.
Our test set additionally included several antibiotics not
applicable for treatment of Gram-negative pathogens. However,
these substances (vancomycin, erythromycin) can be used
to detect OM defects in Gram-negatives (Wu et al., 2005).
The deletion of bamB reduced the MIC values at least 4-
fold for ampicillin/sulbactam, ceftazidime, fosfomycin and
vancomycin (Table 2). The complementation with arabinose-
induced BamB (bamB BamB+) restored the resistance
against these antibiotics with the exception of fosfomycin.
In summary, our data demonstrate that bamB deletion leads
to a moderate increase in antibiotic susceptibility against
several antibiotics.
Interestingly, for some of the tested antibiotics, we could
observe at least a 4-fold reduction of the MIC for both the
PA14 and the ID72 conditional surA mutant. This was the case
for ticarcillin/clavulanate (PA14 32→6 mg/l; ID72 >256→64
mg/l), ceftazidime (PA14 2→0.5 mg/l; ID72 >256→8 mg/l),
levofloxacin (PA14 0.38→0.094 mg/l; ID72 1.5→0.064 mg/l),
ciprofloxacin (PA14 0.19→0.038 mg/l; ID72 0.38→0.064 mg/l)
and vancomycin (PA14 >256→12 mg/l; ID72 >256→64 mg/l).
For the SurA-depleted strain in the PA14 background, we
additionally observed a reduced MIC for ampicillin/sulbactam
(PA14 >256→24 mg/l). Moreover, the mutant in the ID72
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FIGURE 5 | SurA deletion leads to attenuated virulence in the Galleria
mellonella infection model. In total, 60 G. mellonella larvae per group were
infected in 3 independent experiments with a CFU of 12 ± 2 for the indicated
time period and survival of larvae was monitored by touching with a forceps.
The conditional surA mutant strain was tested both when expressing SurA
(SurA+) and after depletion of SurA (SurA–) at the time point of infection.
Please note that the survival curves of WT, bamB, bamC, and hlpA are
identical. Statistical analysis was performed using a log rank test (Mantel-Cox
test). A significant difference between WT and the conditional surA mutant was
observed (p < 0.0001).
background displayed a reduced MIC for cefepime (>32→3
mg/l). Strain-specific differences mediated by SurA depletion
were found for ampicillin/sulbactam (increased sensitivity of
PA14 surA but not ID72 surA) and cefepime (increased sensitivity
of ID72 surA but not PA14 surA). Strikingly, in the SurA-depleted
multidrug-resistant clinical bloodstream isolate ID72, the MIC
values for cefepime, ceftazidime and levofloxacin were reduced
to such an extent that according to the current EUCAST Clinical
Breakpoint Tables (v. 8.1.), ID72 was re-sensitized to treatment
with these antibiotics. In the case of ticarcillin/clavulanate, the
MIC value was reduced. However, it did not drop below the
critical breakpoint. Taken together, our data demonstrate that
SurA depletion leads to an increased susceptibility against some
representatives of clinically relevant antibiotics, even in the case
of a multidrug-resistant Pa strain. Thus, SurA could possibly
be used as a drug target to re-sensitize resistant strains to
antibiotic therapy.
DISCUSSION
Pa is a difficult-to-treat pathogen and, compared to other Gram-
negative bacteria, associated with a higher mortality that cannot
be attributed to resistance only (Aloush et al., 2006; Willmann
et al., 2014; Thaden et al., 2017). Often colistin is considered as a
last resort antibiotic to defeat infections caused by Pa, however,
it has severe side effects and is rather nephrotoxic (Jeannot et al.,
2017). Therefore, novel drugs and drug targets are required to
control Pa infections (Perez et al., 2016).
The BAM complex and associated chaperones are responsible
for the transport and insertion of the great majority of OMPs
into the Gram-negative OM. Previous studies already highlighted TA
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the importance of the BAM complex as a putative drug target
for several Gram-negative bacteria (Vertommen et al., 2009;
Namdari et al., 2012; Hagan et al., 2015; Krachler, 2016; Weirich
et al., 2017; Storek et al., 2018). The delivery of OMPs to the BAM
complex is performed by the well-known chaperones SurA and
Skp. Interestingly, according to the literature there are striking
differences in the importance of these chaperones for OMP
biogenesis. In Ec and Ye, SurA seems to play a major and Skp
only a minor role for OMP biogenesis (Sklar et al., 2007). In
contrast, in Neisseria meningitidis Skp but not SurA seems to
play the major role for OMP biogenesis (Volokhina et al., 2011).
According to the importance of Pa in clinical settings, we wanted
to know which of the components of the BAM complex might be
more useful as a target.
Therefore, we analyzed the role of distinct components of
the BAM complex and the periplasmic chaperones HlpA/Skp
and SurA for OM integrity and composition, virulence and
antibiotic resistance. The main findings of this study are that
depletion of SurA severely alters Pa OMP composition, which
in consequence strongly influences OM integrity as well as
resistance to bile salts, complement activity and antibiotics,
which altogether leads to attenuated virulence and enhanced
susceptibility to several antibiotics even in a multidrug-resistant
bloodstream isolate of Pa.
A comparably lower impact of the bamB deletion on Pa
sensitivity against antimicrobial substances is perfectly in line
with the milder phenotypes and minor changes in OMP
composition of the bamB mutant. Similar findings have been
made with Ec and Ye (Charlson et al., 2006; Weirich et al.,
2017). Deletion of the skp homolog hlpA and the BAM complex
component bamC did not result in obvious phenotypes in our
hands. In addition, none of these deletion mutants showed
attenuation of virulence in theG.mellonella infectionmodel. This
is in line with previous studies on Skp in Ec where it was shown
that Skp/HlpAmay play only a minor role as chaperone to deliver
OMPs to the BAM complex (Sklar et al., 2007).
Recently, it was asked whether BamB might be the achilles’
heel for targeting Klebsiella pneumoniae (Kp) infection (Krachler,
2016). It was found that deletion of bamB led to a 15-fold
decrease in Kp adherence to retinal, intestinal and lung epithelial
cells and consequently decreased invasion. bamB deletion had a
pleiotropic effect on the profile of OMPs including a decrease
of some porins as well as of type I fimbriae. Moreover,
bamB deletion led to a significant attenuation of virulence
in mice challenged intraperitoneally with Kp (Hsieh et al.,
2016). Attenuation of virulence of a bamB deletion mutant
was also found during Ye infection (Behrens et al., 2001). In
vitro assays showed increased sensitivity against antimicrobial
components such as bile salts and complement activity. In
addition, bamB deletion mutants of Ye were sensitized to various
antibiotics (typically not active against Gram-negative bacteria),
such as vancomycin (Weirich et al., 2017). Like in Kp, several
porins as well as the autotransporter invasin were significantly
decreased in Ye. Another study addressing the role of BamB
in Pa PAO1 already showed that bamB deletion also leads to
sensitization against lysozyme, vancomycin and cefotaxime (Lee
et al., 2017), which could be confirmed in our study. However,
in contrast to Ye or Kp, neither increased sensitivity against
human serum nor attenuation of virulence was observed. A
common impact of bamB deletion in various species seems to
be the reduction of the abundance of some porins (Malinverni
et al., 2006; Hagan et al., 2010). In line with this, in the Pa
bamB deletion mutant, porins such as OpdO (>93% reduced)
and OprB (45% reduced) were found in lower levels in the
OM. Some autotransporters like AaaA (67% reduced) and PlpD
(52% reduced) were also found in lower levels in the OM. This
is in agreement with previous studies, where it was observed
that BamB-dependency of autotransporter proteins seemed to be
correlated with the number of β-strands contained. Especially
those proteins possessing a large number of β-strands were
negatively affected by the absence of BamB, whereas others were
not (Rossiter et al., 2011; Weirich et al., 2017). However, these
effects were rather moderate. Thus, BamB may contribute to the
assembly of porins and autotransporters in Pa, but in contrast to
the function of BamB in Kp or Ye, the rather mild phenotypes
we found upon deletion of bamB in Pa PA14 do not justify
considering it as a promising target for drug development from
our point of view. Nonetheless, given the results that have been
obtained with e.g., Pa PAO1 and Salmonella (Namdari et al.,
2012; Lee et al., 2017), it cannot be ruled out that the importance
of BamB for OM composition and consequently the resulting
phenotypes might vary significantly between strains and species.
The most interesting candidate as a putative drug target
addressed in this study was found to be SurA. We recognized
quite early during our studies that SurA might play an important
role in Pa PA14, because it was not feasible to generate an in-
frame deletion mutant of surA. This indicated that surA might
be essential in PA14, which would be in line with the findings of
various other groups since there was no viable surA transposon
mutant detected in their transposon libraries of different Pa
strains (Skurnik et al., 2013; Lee et al., 2015; Turner et al.,
2015) and also with own unpublished observations. Nevertheless,
there is one transposon library in PA14 that contains three
different mutants with transposons inserted into surA (Liberati
et al., 2006). The transposon mutant with the ID38436 included
in the available PA14NR set showed a similar phenotype like
the conditional surA mutant in various assays and no SurA
was detectable by Western blot analysis (data not shown). The
insertion site of this mutant is located at the very beginning of
the gene (at base pair 17), indicating inactivation of the gene.
One possible explanation that this mutant is viable might be that
compensatory mutations occurred in this transposon mutant.
Altogether, we assume that SurA in Pa is essential in contrast
to other Gram-negative bacteria. Nevertheless, the phenotypes
observed in the SurA depletion strain of Pa are very similar to
those of the deletion mutant in Ye (Weirich et al., 2017).
While bamB deletion only leads to mild alteration in the
OM composition, the depletion of SurA disturbed the insertion
of a wide variety of OMPs of different functions, resulting
in a drastically altered OM composition. Since the proper
composition of the Gram-negative OM is important for its
function as an impermeable barrier for many substances, it is
reasonable that the reduced amount of several OMPs resulted in
a higher permeability to the fluorescent dye NPN.
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The permeability barrier of the OM and the export of
substances by eﬄux pumps are the main reasons for the high
intrinsic resistance of Pa against many antibiotics (Nikaido, 1989;
Poole, 2001). The reduced integrity of the OM could be an
important reason, why the conditional surAmutants of PA14 and
ID72were better accessible to antibiotics such as vancomycin that
are usually not able to cross the OM of Pa and reach their target
inside the bacterial cell. Nevertheless, it cannot be excluded that
other effects such as alteration in OMP composition or stress
response may contribute to the increased antibiotic sensitivity.
Thus, an inhibition of SurA could possibly permit a re-purposing
of approved antimicrobials, currently active only against Gram-
positive pathogens, for use in Gram-negative bacteria. Of course
this could work only if (i) the current limitation of use is a
result of the inefficient entry and if (ii) the antimicrobial target is
conserved and also present in the Gram-negative species. These
data are in line with previous data found for the commensal Ec
K12 as well as Ye (Tamae et al., 2008; Weirich et al., 2017).
However, a critical precondition to consider SurA as a
target specifically in species like Pa would be to break the
resistance against therapeutically used antibiotics of multidrug-
resistant strains. By using a conditional ID72 surA mutant this
could indeed be demonstrated for various antibiotics such as
cephalosporins and fluoroquinolones.
In summary, from all the investigated factors, SurA was
identified as the best target candidate to restore the sensitivity
against some antibiotics by distortion of the OM specifically
in multidrug-resistant strains. In the surA conditional mutant
we found that the OM contained a higher amount of some
single proteins like the OprM family porins OprM, OpmB and
OpmG that are associated with the MexAB and MexXY eﬄux
pumps (Poole, 2000). They are involved in mediating resistance
against β-lactams, chloramphenicol, macrolides, quinolones
and tetracycline (Li et al., 1995; Masuda et al., 2000), and
aminoglycosides (Mao et al., 2001), respectively. Their increased
abundance indicates that these porins are no dedicated substrates
of SurA and their insertion into the OM may be facilitated in
a different way, independent of SurA. OprM actually assembles
into a trimer (Akama et al., 2004). It has been previously
observed that a distinct subset of OMPs belonging to the
TolC-like BAM substrates (i.e., multimeric with each monomer
having only few β-strands) were affected only weakly by the
absence of the non-essential Bam proteins and periplasmic
chaperones. However, they were highly dependent on the
essential Bam proteins BamA and BamD (Mahoney et al.,
2016; Weirich et al., 2017). This might also apply to OprM
family porins. Also the associated eﬄux pumps were found
in a relatively higher amount in the OM of the conditional
surA mutant, but this does not seem to influence its antibiotic
sensitivity (Table 2).
With the exception of OprM, OpmG, andOpmB,many porins
were detected in a significantly lower amount in the OM of the
conditional surA mutant, including the most striking reduction
observed for members of the OprD family (OpdO, OpdN,
OpdP, and OprD). This may lead to a deprivation of nutrients,
since most of these porins are specific transporters for different
nutrients like pyroglutamate (OpdO), glycine-glutamate (OpdP),
arginine (OprD and OprQ) and glucose (OprB) (Chevalier et al.,
2017) and could also contribute to attenuation.
Besides the porins, also other groups of OMPs were strikingly
affected by the depletion of SurA. We found that especially
siderophore receptors and other TonB-dependent receptors (e.g.,
FpvA or FecA) (Pederick et al., 2015; Luscher et al., 2018) as well
as different autotransporter proteins (e.g., PlpD or AaaA) were
absent or less abundant in the OM upon depletion of SurA. The
mRNA expression analysis suggested that the autotransporter
protein PlpD is also a true substrate of SurA, similar to the
autotransporter Inv of Ye (Weirich et al., 2017). This means that
these proteins are reduced in abundance because they cannot use
any alternative insertion pathway when SurA is depleted. Thus
they presumably are degraded by periplasmic proteases such as
DegP (Sklar et al., 2007).
The finding that so many proteins involved in iron acquisition
and transport were completely or almost completely absent in
the conditional surA mutant, including the pyoverdine receptor
FpvA, the ferric citrate transporter FecA and the ferrichrome
receptor FiuA, suggests a reduced fitness of the conditional
surA mutant under iron-limited conditions. This is in line with
our findings that SurA depletion strongly affects growth in LB
medium under iron-restricted conditions. In addition, it was
previously shown that deletion of fiuA, besides its involvement
in iron acquisition, leads to pleiotropic effects such as reduction
of elastase levels and reduced virulence in an airway infection
model (Lee et al., 2016). Therefore, the reduced abundance of
siderophore receptors and the associated downstream effects
could also contribute to attenuation of the SurA-depleted PA14
in the G. mellonella infection model.
Furthermore, the significantly reduced amount of the LptD/E
complex (Chimalakonda et al., 2011) in the conditional surA
mutant might result in an altered level of LptD in the OM (Lo
Sciuto et al., 2018). The stable LptD/E complex is present at
the OM and functions in the final stages of LPS assembly. The
lipopolysaccharide transport (Lpt) is responsible for transporting
LPS from the periplasmic side of the OM to the cell surface
(Balibar and Grabowicz, 2016; Andolina et al., 2018). In line with
previous studies (Vertommen et al., 2009; Weirich et al., 2017),
LptD was shown to be a true substrate of SurA. Furthermore,
it was shown that LptE depletion leads to reduced functionality
of LptD resulting in impaired cell envelope integrity, reduced
virulence and decreased antibiotic resistance (Lo Sciuto et al.,
2018), which identifies LptD as a promising target for drug
development. Actually, LptD is already addressed as a drug target
by the macrocyle inhibitor Murepavadin (Polyphor POL7080),
which is currently tested in a phase III clinical trial (Martin-
Loeches et al., 2018). This fact renders the concept of a SurA
inhibitor -which is able to significantly reduce the cellular LptD
protein levels- even more attractive.
The global changes in the OM composition of the conditional
surA mutant including the reduced levels of many porins
important for nutrient uptake, iron transport systems and
proteins involved in LPS transport may in sum accumulate in
reduced fitness. This is in line with the results of theG. mellonella
infection model, since the larvae showed a prolonged time to
death when infected with the conditional PA14 surAmutant. For
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the in vivo experiments, the leakiness of the araC-PBAD promoter
(Meisner and Goldberg, 2016), still resulting in some mRNA
expression, was actually a convenient feature: a partial reduction
of SurA simulates the potential inhibition of the protein by a
putative SurA inhibitor more realistically than a clean deletion.
Taken together, SurA is an important protein in Pa
determining proper composition of the OM and seems to be an
attractive target for an antiinfective drug. Its inhibition may lead
to reduced fitness, may dampen multidrug resistance and could
simultaneously render Pa accessible to various antibiotics that are
usually not effective because of the OM barrier.
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